Primary Device ID | 00628055344001 |
NIH Device Record Key | 93da11e5-9485-4eeb-9c3b-aa0412d79086 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | revogene™ |
Version Model Number | 130840 |
Catalog Number | 130840 |
Company DUNS | 202672846 |
Company Name | GenePoc Inc |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | false |
Lot Batch | false |
Serial Number | true |
Manufacturing Date | false |
Expiration Date | false |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com | |
Phone | 1-844-616-1544 |
fran@mdcassoc.com |
Device Issuing Agency | Device ID |
---|---|
GS1 | 00628055344001 [Primary] |
OOI | Real Time Nucleic Acid Amplification System |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 3 |
Public Version Date | 2018-07-06 |
Device Publish Date | 2017-12-29 |
00628055344070 - GenePOC™ Carba | 2019-06-03 The GenePOC™ Carba assay, performed on the revogene™ instrument, is a qualitative in vitro diagnostic test designed for the |
00628055344087 - GenePOC™ Strep A | 2019-05-08 The GenePOC Strep A assay, performed on the revogene instrument, is an automated, qualitative in vitro diagnostic test that util |
00628055344001 - revogene™ | 2018-07-06The revogene™ instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assays in clinical laboratories. The revogene is capable of automated lysis and dilution of samples originating from various clinical specimen types. revogene performs automated amplification and detection of target nucleic acid sequences by fluorescence-based real-time PCR. |
00628055344001 - revogene™ | 2018-07-06 The revogene™ instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assa |
00628055344018 - GenePOC™ GBS LB | 2018-07-06 The GenePOC™ GBS LB assay performed on the revogene™ instrument is a qualitative in vitro diagnostic test designed to detect |
00628055344025 - GenePOC™ CDiff | 2018-07-06 The GenePOC™ CDiff assay performed on the revogene™ instrument is a qualitative in vitro diagnostic test that utilizes autom |
00628055344032 - MOCK PIE | 2018-07-06 The MOCK PIE is a re-usable PIE intended for use in conjunction with the revogene™ instrument and GenePOC assays. The MOCK PIE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() REVOGENE 87514391 5784546 Live/Registered |
Genepoc Inc. 2017-07-03 |